Scientific publications

Here you will find a selection of scientific publications from Idogen’s research group and collaborators:


Exploitation of the IDO pathway in the therapy of Rheumatoid Arthritis.

Williams RO.

Int J Tryptophan Res, 2013; 6 (Suppl. 1).


Zebularine induces long-term survival of pancreatic islet allotransplants in streptozotocin treated diabetic rats.

Nittby H, Ericsson P, Förnvik K, Strömblad S, Jansson L, Skagerberg G, Widegren B, Sjögren HO, Salford LG.

PLoS One, 2013; 8, e71981.


An epigenetic mechanism for high, synergistic expression of indoleamine 2, 3-dioxygenase 1 (IDO1) by combined treatment with Zebularine and IFN-γ: Potential therapeutic use in autoimmune diseases.

Xue Z-T, Sjögren H-O, Salford LG, Widegren B.

Mol Immunol, 2012; 51, 101–111.


Low dose Zebularine treatment enhances immunogenicity of tumor cells.

Liu H, Xue ZT, Sjögren HO, Salford LG, Widegren B.

Cancer Lett, 2007; 257, 101–115.